583 related articles for article (PubMed ID: 32054868)
1. Continued versus Suspended Cardiac Resynchronization Therapy after Left Ventricular Assist Device Implantation.
Roukoz H; Bhan A; Ravichandran A; Ahmed MM; Bhat G; Cowger J; Abdullah M; Dhawan R; Trivedi JR; Slaughter MS; Gopinathannair R
Sci Rep; 2020 Feb; 10(1):2573. PubMed ID: 32054868
[TBL] [Abstract][Full Text] [Related]
2. Impact of QRS Duration and Ventricular Pacing on Clinical and Arrhythmic Outcomes in Continuous Flow Left Ventricular Assist Device Recipients: A Multicenter Study.
Gopinathannair R; Roukoz H; Trivedi JR; Cowger J; Bhan A; Ravichandran A; Bhat G; Birks EJ; Slaughter MS; Ahmed MM
J Card Fail; 2019 May; 25(5):355-363. PubMed ID: 30797964
[TBL] [Abstract][Full Text] [Related]
3. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy.
Adelstein EC; Schwartzman D; Jain S; Bazaz R; Wang NC; Saba S
Europace; 2017 Oct; 19(10):1689-1694. PubMed ID: 27856539
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Resynchronization Therapy and Clinical Outcomes in Continuous Flow Left Ventricular Assist Device Recipients.
Gopinathannair R; Roukoz H; Bhan A; Ravichandran A; Ahmed MM; Familtsev D; Bhat G; Cowger J; Abdullah M; Sandesara C; Dhawan R; Birks EJ; Trivedi JR; Slaughter MS
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29907652
[TBL] [Abstract][Full Text] [Related]
6. Effect of Continued Cardiac Resynchronization Therapy on Ventricular Arrhythmias After Left Ventricular Assist Device Implantation.
Schleifer JW; Mookadam F; Kransdorf EP; Nanda U; Adams JC; Cha S; Pajaro OE; Steidley DE; Scott RL; Carvajal T; Saadiq RA; Srivathsan K
Am J Cardiol; 2016 Aug; 118(4):556-9. PubMed ID: 27328958
[TBL] [Abstract][Full Text] [Related]
7. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875
[TBL] [Abstract][Full Text] [Related]
8. Association between biventricular pacing and incidence of ventricular arrhythmias in the early post-operative period after left ventricular assist device implantation.
Chou A; Larson J; Deshmukh A; Cascino TM; Ghannam M; Latchamsetty R; Jongnarangsin K; Oral H; Morady F; Bogun F; Aaronson KD; Pagani FD; Liang JJ
J Cardiovasc Electrophysiol; 2022 May; 33(5):1024-1031. PubMed ID: 35245401
[TBL] [Abstract][Full Text] [Related]
9. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN
JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796
[TBL] [Abstract][Full Text] [Related]
10. Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy.
Singh JP; Solomon SD; Fradley MG; Barac A; Kremer KA; Beck CA; Brown MW; McNitt S; Schleede S; Zareba W; Goldenberg I; Kutyifa V;
JAMA; 2019 Nov; 322(18):1799-1805. PubMed ID: 31714987
[TBL] [Abstract][Full Text] [Related]
11. Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry.
Cikes M; Jakus N; Claggett B; Brugts JJ; Timmermans P; Pouleur AC; Rubis P; Van Craenenbroeck EM; Gaizauskas E; Grundmann S; Paolillo S; Barge-Caballero E; D'Amario D; Gkouziouta A; Planinc I; Veenis JF; Jacquet LM; Houard L; Holcman K; Gigase A; Rega F; Rucinskas K; Adamopoulos S; Agostoni P; Biocina B; Gasparovic H; Lund LH; Flammer AJ; Metra M; Milicic D; Ruschitzka F;
Eur J Heart Fail; 2019 Sep; 21(9):1129-1141. PubMed ID: 31410955
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
[TBL] [Abstract][Full Text] [Related]
13. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ
Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mortality, LVAD implant, or heart transplant in primary prevention cardiac resynchronization therapy recipients: The HF-CRT score.
Nauffal V; Tanawuttiwat T; Zhang Y; Rickard J; Marine JE; Butcher B; Norgard S; Dickfeld T; Ellenbogen KA; Guallar E; Tomaselli GF; Cheng A
Heart Rhythm; 2015 Dec; 12(12):2387-94. PubMed ID: 26190316
[TBL] [Abstract][Full Text] [Related]
15. Cardiac resynchronization therapy and outcomes in patients with left ventricular assist devices: a systematic review and meta-analysis.
Voruganti DC; Briasoulis A; Chaudhry M; Alvarez P; Cotarlan V; Bhama JK; Giudici M
Heart Fail Rev; 2019 Mar; 24(2):229-236. PubMed ID: 30259285
[TBL] [Abstract][Full Text] [Related]
16. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
[TBL] [Abstract][Full Text] [Related]
17. Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators.
Adelstein EC; Althouse AD; Davis L; Schwartzman D; Bazaz R; Jain S; Wang N; Saba S
J Cardiovasc Electrophysiol; 2019 Mar; 30(3):348-356. PubMed ID: 30575185
[TBL] [Abstract][Full Text] [Related]
18. Biventricular Pacing Versus Right Ventricular Pacing in Patients Supported With LVAD.
Chung BB; Grinstein JS; Imamura T; Kruse E; Nguyen AB; Narang N; Holzhauser LH; Burkhoff D; Lang RM; Sayer GT; Uriel NY
JACC Clin Electrophysiol; 2021 Aug; 7(8):1003-1009. PubMed ID: 34217657
[TBL] [Abstract][Full Text] [Related]
19. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
[TBL] [Abstract][Full Text] [Related]
20. Cardiac resynchronization therapy is associated with a reduction in ICD therapies as it improves ventricular function.
Galve E; Oristrell G; Acosta G; Ribera-Solé A; Moya-Mitjans À; Ferreira-González I; Pérez-Rodon J; García-Dorado D
Clin Cardiol; 2018 Jun; 41(6):803-808. PubMed ID: 29604094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
